---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-185382"
form_type: "8-K"
ticker: "KALV"
cik: "0001348911"
company_name: "KalVista Pharmaceuticals, Inc."
filed_at: "2025-08-21T23:59:59+00:00"
generated_at: "2026-05-17T10:46:57.238712+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# KalVista sets June 18, 2026 as annual meeting date; stockholder deadlines revised

## Summary
- 2026 Annual Meeting set for June 18, 2026; changed >30 days from 2025 meeting.
- Stockholder proposals for proxy inclusion due January 6, 2026.
- Other proposals or director nominations due August 31, 2025 (10 days after this 8-K).
- Universal proxy rule compliance required for soliciting proxies in support of non-company nominees.
- Advance notice procedures per Bylaws apply; notice to Cambridge, MA address.

## SEC filing metadata
- accession: 0001193125-25-185382
- form_type: 8-K
- ticker: KALV
- cik: 0001348911
- company_name: KalVista Pharmaceuticals, Inc.
- filed_at: 2025-08-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348911/000119312525185382/0001193125-25-185382-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348911/000119312525185382/d928596d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-185382
- JSON: https://secwatch.observer/filing/0001193125-25-185382.json
- Plain text: https://secwatch.observer/filing/0001193125-25-185382.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.